All In MedTech

Device Trial Radar · NCT04757116

Post-Market Study to Assess iTind Safety in Comparison to UroLift

A Post-Market, Prospective, Randomized, Controlled, Multicenter International Study to Assess the Safety of the Temporarily Implanted Nitinol Device (iTind) Compared to the UroLift® System in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)

Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 256 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

256

Planned (sponsor's estimate)

Start

Sep 26, 2022

Primary completion

Jul 15, 2027

Study completion May 31, 2030

Sponsor

Lead sponsor
Olympus Corporation of the AmericasPublic (7733.T)
Sponsor type
Industry
Collaborators
Olympus Europe SE & Co. KG
First posted
Feb 17, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study objective is to evaluate the efficacy and safety of the iTind device compared to UroLift.

Conditions

  • Benign Prostatic Hyperplasia (BPH)

Interventions

  • iTindDevice

    The iTind is implemented for 5-7 days

  • UroLiftProcedure

    UroLift is a minimally invasive procedure where permanent implants are placed in the prostate.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Difference in change of IPSS from baseline between iTind and UroLift groups at 3 monthsTime frame: 3 months

Locations

19 sites in 2 countries. Site status is shown where the registry gives one.

  • Mayo Clinic Arizona

    Phoenix, Arizona · Recruiting

  • Arizona Urology Specialists

    Tucson, Arizona · Terminated

  • Urology Associates of Central California

    Fresno, California · Recruiting

16 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.